$345.60
+7.38 (+2.18%)
At Close: Jun 04, 2026
FTC, Amgen strike deal to allow $27.8 billion Horizon Therapeutics acquisition to move forward
08:49am, Friday, 01'st Sep 2023
The FTC had filed a lawsuit in May seeking to block the acquisition, arguing that the deal would "stifle competition" in the pharmaceutical industry.
How Much Pain Will Lower Medicare Prices Cause for Pharma Stocks?
07:01am, Friday, 01'st Sep 2023
Major pharmaceutical companies including Johnson & Johnson NYSE: JNJ, Novartis AG NYSE: NVS, Bristol-Myers Squibb (NYSE: BMY), Merck & Co., Inc. NYSE: MRK, Eli Lilly & Co. NYSE: LLY and Amgen In
AMGEN TO PRESENT AT THE 2023 WELLS FARGO HEALTHCARE CONFERENCE AND THE CITI GLOBAL HEALTHCARE CONFERENCE
07:30pm, Thursday, 31'st Aug 2023
THOUSAND OAKS, Calif. , Aug. 31, 2023 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 2023 Wells Fargo Healthcare Conference at 9:30 a.m.
Is This the Green Light Biotech Stocks Have Been Waiting For?
07:53am, Thursday, 31'st Aug 2023
Biotech stocks have underperformed the broad market since May, when the Federal Trade Commission moved to block Amgen's proposed acquisition of Horizon Therapeutics. The FTC was aiming to prevent Amge
Medicare's First Price Negotiation List Targets Expensive Drugs (Revised)
04:31am, Thursday, 31'st Aug 2023
The negotiations with participating drug companies are likely to happen in 2023 and 2024 with the negotiated prices, if any, going into effect in 2026.
Merck, Amgen, AbbVie products among first 10 drugs selected for Medicare price negotiations
07:50am, Tuesday, 29'th Aug 2023
Medicare on Tuesday announced the first 10 drugs selected for price negotiations, launching a historic and highly contentious process with big implications for pharmaceutical companies, taxpayers and
FTC Attempts To Block Major Biotech Company Merger
11:11pm, Monday, 28'th Aug 2023
The FTC's lawsuit against Amgen-Horizon deal is based on unprecedented speculative concerns and would have cleared months ago if it followed well-established precedent.
Why Amgen (AMGN) is a Top Value Stock for the Long-Term
11:17am, Monday, 28'th Aug 2023
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Horizon Therapeutics shares climb after FTC pauses challenge of deal with Amgen
08:03am, Monday, 28'th Aug 2023
Shares of Horizon Therapeutics PLC HZNP, +0.31% gained more than 5% premarket on Monday after the Federal Trade Commission last week paused its legal challenge to Amgen Inc.'s AMGN, -0.09% deal to acq
August MDA Breakout Stocks Week 35 - 2023: High-Frequency Gainers To Give You An Edge
06:05am, Monday, 28'th Aug 2023
Two new sample Breakout Stocks for Week 35 curated by the MDA model for a 10% short-term upside along with a Dow pick. The Momentum Gauges, S&P 500 Gauges, and Weekly Gauges all continue negative afte
US FTC suspends challenge to block Amgen's $27.8 bln deal for Horizon Therapeutics
11:43am, Saturday, 26'th Aug 2023
The U.S. Federal Trade Commission (FTC) has suspended its challenge of Amgen's $27.8 billion purchase of Horizon Therapeutics , allowing the FTC to consider whether the agency should settle the case,
FTC Pauses Challenge to Amgen's $27.8 Billion Deal for Horizon Therapeutics
11:09am, Saturday, 26'th Aug 2023
The move gives the agency time to weigh a settlement that would allow the deal to close with conditions.
4 Surefire Stocks to Buy in the Next Bear Market
10:00am, Thursday, 24'th Aug 2023
Altria is able to stand up to tough environments because consumers are slow to give up their bad habits. Procter & Gamble is the powerhouse name behind some of the world's best-known brands.
Health care sector holding up well: Strategist says look at United Healthcare, Merck, Amgen
02:22pm, Tuesday, 22'nd Aug 2023
Why are UnitedHealth (UNH), Merck & Company (MRK), Johnson & Johnson (JNJ), and Amgen (AMGN), this strategist's top health care stock picks? Freedom Capital Markets Chief Global Strategist Jay Woods j
These Are the ONLY 3 Biotech Stocks to Consider in August 2023
04:20pm, Monday, 21'st Aug 2023
The world may be on the mend from the grip of the global pandemic, but the consistent drumbeat for medical innovation remains as unyielding as ever. Amid this backdrop, Biotech stocks present a beacon
Sign In
Buy AMGN